Synergism between penicillins and lysozyme. Data which led to the synthesis of a new antibiotic salt: lysozyme ampicillinate. 3.
D000667:Ampicillin / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000032:analysis / Q000138:chemical synthesis*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002648:Child; D004357:Drug Synergism; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D008712:Methicillin / Q000494:pharmacology; D009113:Muramidase / Q000494:pharmacology* / Q000627:therapeutic use; D009254:Nafcillin / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology* / Q000627:therapeutic use; D012213:Rheumatic Fever / Q000188:drug therapy; D012485:Salmonella typhi / Q000187:drug effects; D012486:Salmonella typhimurium / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D010406:Penicillins; D009254:Nafcillin; D000667:Ampicillin; D009113:Muramidase; D008712:Methicillin